Novartis data show once-daily Ultibro® Breezhaler® is superior in COPD
Novartis presented new data that demonstrated once-daily Ultibro® Breezhaler® (indacaterol/glycopyrronium bromide) was superior in reducing exacerbations (flare ups) and improving lung function compared to twice-daily Seretide®Accuhaler®* (salmeterol/fluticasone (SFC)), in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 8, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Industry News Respiratory copd exacerbation indacaterol/glycopyrronium bromide Latest News lung function Source Type: news

First global report on the status of CPD in pharmacy
For the first time, pharmacy organisations can refer to a snapshot of continuing professional development (CPD) around the world, make comparisons with the situation in their own countries and use this information to improve how their pharmacists maintain their competence. (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 5, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Association News continuing education cpd fip Latest News Professional development in Pharmacy Source Type: news

Web address ending .pharmacy to launch
Early in 2015, patients will have a new tool that will enable them to know for sure whether they are obtaining medicines, health information and services from websites that are authentic and safe. (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 5, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Patient safety fip Health information Latest News website domain Source Type: news

Boost for pharmacy workforce in Africa and the rest of the world
A centre of excellence that aims to increase capacity for pharmacy education in the African region was officially launched at the International Pharmaceutical Federation’s World Congress of Pharmacy and Pharmaceutical Sciences. (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 4, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Association News Centre of excellence Education Initiative Latest News Pharmacy practice Source Type: news

An aroma sprayed up the nose could help treat anorexia
Fragrances found naturally in plants are proving to be good candidates for new products to treat anorexia, according to a study presented at the World Congress of Pharmacy and Pharmaceutical Sciences. (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 4, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Industry News anorexia nervosa benzylacetone ghrelin Latest News Source Type: news

Changing practice to improve safety
B. Braun Medical Ltd has a long heritage in the delivery of intravenous pharmaceuticals and associated products to markets in the UK and Europe. (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 2, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Industry News Policy & practice injectable medicines Latest News patient safety pharmacy workshop Source Type: news

FIP world congress opens in Bangkok
The 74th International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences opened in Bangkok, Thailand, with issues of access as its overall theme. (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 1, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Association News access to health congress fip Latest News Source Type: news

New statement on pharmacists' professional standards issued
Consideration should be given to the development of transdisciplinary codes of ethics, the International Pharmaceutical Federation (FIP) recommends in a new statement on codes of ethics for pharmacists. (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 1, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Association News Guidelines code of ethics fip Latest News professional standards Source Type: news

Takeda to submit data for pioglitazone containing medicines including ACTOS
Takeda Pharmaceutical Company Limited announced the completion of the post-marketing commitment and submissions of data from a 10-year epidemiology study to regulatory authorities including the United States Food and Drug Administration, the European Medicines Agency and the Japanese Pharmaceuticals and Medical Devices Agency for pioglitazone containing medicines, including ACTOS (pioglitazone HCl). (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 1, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Diabetes Oncology ACTOS Latest News pioglitazone pioglitazone HCl regulatory bodies takeda Source Type: news

Pharmaceutical physicians ‘overwhelming support’ for clinical trial transparency
The Faculty of Pharmaceutical Medicine has released survey findings on the publication of results and access to clinical trial data. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 28, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Association News Clinical trials Industry News Faculty of Pharmaceutical Medicine Latest News transparency Source Type: news

Bristol-Myers Squibb hepatitis C drug EU go ahead
Bristol-Myers Squibb has announced that the European Commission has approved Daklinza for use in combination with other medicinal products across genotypes 1, 2, 3 and 4 for the treatment of chronic hepatitis C virus infection in adults. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 28, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Hepatic disorders bristol-myers squibb Daklinka european commission hepatitis c virus Latest News Source Type: news

New NICE position on lenalidomide
NICE has issued final draft guidance recommending lenalidomide as an option for treating myelodysplastic syndromes. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 20, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Haematology celgene Latest News lenalidomide myelodysplastic syndromes nice revlimid Source Type: news

UKCPA autumn symposium 2014
The Chair of the UKCPA, Mark Borthwick, is delighted to announce that registration is now open for the UKCPA Autumn Symposium. This event has been endorsed by the Royal Pharmaceutical Society. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 18, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick UK Conference and Symposia Latest News symposium ukcpa United Kingdom Clinical Pharmacy Association Source Type: news

Sativex® recommended by the AWMSG
The All Wales Medicines Strategy Group is the first national assessment body to recommend Sativex Oromucosal Spray for use within NHS Wales for the treatment of spasticity associated with multiple sclerosis. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 18, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Industry News Neurology All Wales Medicines Strategy Group AWMSG bayer healthcare Latest News multiple sclerosis Sativex® Oromucosal Spray Source Type: news

First biosimilar monoclonal antibody distribution licence secured
Mundipharma International Corporation Limited has announced that it has secured a distribution licence from Celltrion Healthcare Hungary Kft for Remsima (infliximab). (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 15, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: *** Editor's Pick Biosimilars mAbs Drug development Dermatology Gastroenterology Rheumatology biosimilar monoclonal antibody infliximab Latest News Mundipharma Remsima Source Type: news